REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $68,000 | -41.4% | 4,175 | 0.0% | 0.01% | -47.8% |
Q3 2021 | $116,000 | -6.5% | 4,175 | 0.0% | 0.02% | -8.0% |
Q2 2021 | $124,000 | +6.0% | 4,175 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $117,000 | -2.5% | 4,175 | 0.0% | 0.02% | -7.4% |
Q4 2020 | $120,000 | +14.3% | 4,175 | 0.0% | 0.03% | +12.5% |
Q3 2020 | $105,000 | -9.5% | 4,175 | -12.1% | 0.02% | +9.1% |
Q2 2020 | $116,000 | +65.7% | 4,750 | 0.0% | 0.02% | +46.7% |
Q1 2020 | $70,000 | -9.1% | 4,750 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $77,000 | +83.3% | 4,750 | +46.2% | 0.02% | +50.0% |
Q3 2019 | $42,000 | 0.0% | 3,250 | 0.0% | 0.01% | +11.1% |
Q2 2019 | $42,000 | -17.6% | 3,250 | 0.0% | 0.01% | -30.8% |
Q1 2019 | $51,000 | +410.0% | 3,250 | +550.0% | 0.01% | +333.3% |
Q4 2018 | $10,000 | -16.7% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $12,000 | -14.3% | 500 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $14,000 | -6.7% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $15,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |